(University of Minnesota) A major step in commercializing the groundbreaking research of Dr. Doris Taylor was achieved recently when the University of Minnesota signed an exclusive, global license agreement with Miromatrix Medical Inc. Dr. Taylor’s research garnered worldwide attention in 2008 when her team announced that it had created a beating animal heart in her laboratory.
Further information:
Related posts:
- Mayo Clinic, HealthForce Minnesota Bring Mobile Science Lab to Area Students
- Arrhythmia Research Technology and Nihon Kohden Sign Multi-Year License Agreement for Predictor(TM) SAECG Software
- Minnesota Partnership Announces Six New Projects
- Malaria research must be based in Africa
- Cardiac Network, Inc. Confirms LOI for Exclusive License Agreement With Pacific Innovations
Posted in